Premium
Stimulation of Interleukin 6‐Like B‐Cell Differentiation Factor Production in Human Adherent Synovial Cells by Recombinant Interleukin 1
Author(s) -
HARIGAI M.,
HARA M.,
NORIOKA K.,
KITANI A.,
HIROSE T.,
SUZUKI K.,
KAWAKAMI M.,
MASUDA K,
SHINMEI M.,
KAWAGOE M,
NAKAMURA H.
Publication year - 1989
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1989.tb01127.x
Subject(s) - immunology , recombinant dna , antibody , medicine , stimulation , interleukin , rheumatoid arthritis , cytokine , microbiology and biotechnology , biology , biochemistry , gene
Abnormal production of immunoglobulin in the joint space is frequently observed in patients with rheumatoid arthritis (RA). We have previously demonstrated that adherent synovial Cells (ASC) from patients with RA are involved in B‐cell differentiation by their spontaneous production of B‐cell differentiation factor (BCDF). The regulation of the production of this factor, however, has not yet been described. We investigated the effects of recombinant interleukin 1α and β (rIL‐1α and rIL‐1β) on the production of BCDF in ASC Increased production of BCDF was observed with increased rIL‐1 concentration. Production of BCDF was detected 3 h after exposure of ASC to rIL‐1 and increased throughout a 48‐h culture. This BCDF, assayed on SKW6‐CL4 cells, was found to share a common active site with interleukin 6. The effect of rIL‐1 was almost neutralized by anti‐IL‐1 antibody and the addition of polymyxin B did not diminish the effect of rIL‐1, indicating that rIL‐1 itself stimulates ASC in vitro. These results suggest that IL‐1 may play a regulatory role in the production of BCDF in synovial tissue.